TCT-320 Impact of Pre-Procedural High-Sensitivity C-Reactive Protein, LDL-C and SYNTAX Score on Outcomes Following Percutaneous Coronary Intervention
Anton Camaj(Columbia University Irving Medical Center), Roxana Mehran(Mount Sinai Hospital), Sabato Sorrentino(Magna Graecia University), Birgit Vogel(Cardiovascular Institute of the South), Pooja Vijay(Mount Sinai Medical Center), Gennaro Giustino(Cardiovascular Institute of the South), Serdar Farhan(Mount Sinai Hospital), George Dangas(Mount Sinai Hospital), Nitin Barman(Icahn School of Medicine at Mount Sinai), Joseph Sweeny(Mount Sinai Hospital), Usman Baber(Icahn School of Medicine at Mount Sinai), Jason C. Kovacic(Victor Chang Cardiac Research Institute), Paul Guedeney(Université Paris Cité), Melissa Aquino(Cardiovascular Institute of the South), Annapoorna Kini(Mount Sinai Medical Center)
Cited by 0
Related Papers
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.3k
Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease
|New England Journal of Medicine|2016|1.5k